Antitumor Effect of the KRAS G12C Inhibitor Sotorasib combined with Radiotherapy and Carboplatin/Cisplatin in human Lung Carcinoma Cell Lines

被引：0
|
作者：
Maltzahn, Christin [1 ]
Patties, Ina [1 ]
Kortmann, Rolf-Dieter [1 ]
Seidel, Clemens [1 ]
Glasow, Annegret [1 ]
机构：
[1] Univ Leipzig, Klin & Poliklin Strahlentherapie, Leipzig, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10-1
引用
收藏
页码：S101 / S101
页数：1
相关论文
共 50 条
  • [41] Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation
    Wu, Markus Y.
    Zhang, Eric W.
    Strickland, Matthew R.
    Mendoza, Dexter P.
    Lipkin, Lev
    Lennerz, Jochen K.
    Gainor, Justin F.
    Heist, Rebecca S.
    Digumarthy, Subba R.
    CANCERS, 2021, 13 (14)
  • [42] Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines
    Ohsaki, Y
    Ishida, S
    Fujikane, T
    Kikuchi, K
    ONCOLOGY, 1996, 53 (04) : 327 - 333
  • [43] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Tereza Vaclova
    Atanu Chakraborty
    James Sherwood
    Sarah Ross
    Danielle Carroll
    J. Carl Barrett
    Julian Downward
    Elza C. de Bruin
    Scientific Reports, 12
  • [44] Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
    Vaclova, Tereza
    Chakraborty, Atanu
    Sherwood, James
    Ross, Sarah
    Carroll, Danielle
    Barrett, J. Carl
    Downward, Julian
    de Bruin, Elza C.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [45] Aurora kinase A inhibition overcomes adaptive resistance to KRAS G12C inhibitor by G1-checkpoint induced apoptosis in KRAS non-small cell lung cancer
    Li, Chendi
    Chang, Jeremy
    Graser, Christopher J.
    Syed, Usman M.
    Nimbalkar, Anahita
    Shen, Yi
    Altschuler, Steve
    Wu, Lani
    Michor, Franziska
    Gong, Xueqian
    Hata, Aaron N.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [46] Aurora kinase A inhibition overcome adaptive resistance to KRAS G12C inhibitor by G1-checkpoint induced apoptosis in KRAS non-small cell lung cancer
    Li, Chendi
    Chang, Jeremy
    Syed, Mohammed U.
    Nimbalkar, Anahita
    Shen, Yi
    Altschuler, Steve
    Wu, Lani
    Gong, Xueqian
    Hata, Aaron
    CANCER RESEARCH, 2023, 83 (07)
  • [47] The First Case Report of Effective Treatment With Sotorasib for Metastatic Atypical Lung Carcinoid Harboring KRAS G12C Mutation and Aggressive Disseminated Lung Metastasis: A Case Report
    Saiki, Masafumi
    Omori, Chisa
    Morikawa, Honami
    Shinohara, Ken
    Shimamura, So
    Ohkoshi, Hiroki
    Uchida, Yoshinori
    Inoue, Tomohiro
    Kondo, Tetsuo
    Ikemura, Shinnosuke
    Soejima, Kenzo
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (01):
  • [48] United Kingdom real-world experience of sotorasib in KRAS G12C mutant non-small cell lung cancer: A British thoracic oncology group review
    Julve, M.
    Kennedy, O.
    Lindsay, C.
    Walters-Davies, R.
    Button, M. R.
    Steele, N.
    McGeogh, A.
    Georgiou, A.
    Goranov, B.
    Farrugia, D.
    Gorf, L.
    Remer, M.
    Shah, R.
    Baijal, S.
    Gennatas, S.
    Geldart, T.
    Daniels, E.
    Watts, L.
    Greystoke, A.
    Newsom-Davis, T.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1061 - S1062
  • [49] Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations
    Shahnam, Adel
    Davis, Alexander
    Brown, Lauren Julia
    Sullivan, Isaac
    Lin, Kevin
    Ng, Chien
    Yeo, Nicholas
    Kong, Benjamin Y.
    Khoo, Trisha
    Warburton, Lydia
    Da Silva, Ines Pires
    Mullally, William
    Xu, Wen
    O'Byrne, Ken
    Bray, Victoria
    Pal, Abhijit
    Mersaides, Antony
    Itchins, Malinda
    Arulananda, Surein
    Nagrial, Adnan
    Kao, Steven
    Alexander, Marliese
    Lee, Chee Khoon
    Solomon, Benjamin
    John, Thomas
    LUNG CANCER, 2025, 201
  • [50] A first-in-human phase 1 study of LY3537982, a novel, highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C mutant advanced solid tumors (trial in progress).
    Ammakkanavar, Natraj Reddy
    Call, Justin
    Shimizu, Toshio
    Kuboki, Yasutoshi
    Liu, Shiyao
    Willard, Melinda D.
    Axelson, Michael
    Heist, Rebecca S.
    Patnaik, Amita
    CANCER RESEARCH, 2022, 82 (12)
12345